Pathogenesis of tubular interstitial nephritis

Contributions to Nephrology

Volumn 169, Issue , 2011, Pages 297-310

  Tanaka, Tetsuhiro ^a,b   Nangaku, Masaomi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; DISEASE MODEL; EPITHELIUM CELL; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE; MESODERM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; KIDNEY TUBULES; MESODERM; NEPHRITIS, INTERSTITIAL; OXIDATIVE STRESS;

EID: 84925941237     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314577     Document Type: Article

References (71)

1. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural- functional correlations in renal disease. II. The correlations. Hum Pathol 1970;1:631-641.
2. Marcussen N: Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 1992;66:265-284.
3. Bohle A, Muller GA, Wehrmann M, Mackensen- Haen S, Xiao JC: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int Suppl 1996;54:S2-S9.
4. Baker RJ, Pusey CD: The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 2004;19:8-11.
5. Buysen JG, Houthoff HJ, Krediet RT, Arisz L: Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant 1990;5:94-99.
6. Myers BD, Newton L: Cyclosporine- induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991;2:S45-S52.
7. Kamisawa T, Okamoto A: IgG4- related sclerosing disease. World J Gastroenterol 2008;14:3948-3955.
8. Schubert GE, Bethke BA: Capillarosclerosis of the renal pelvis: autopsy study for estimating the incidence of phenacetin and paracetamol abuse. Eur Urol 1986;12:327-330.
9. Burrell JH, Yong JL, Macdonald GJ: Experimental analgesic nephropathy: changes in renal structure and urinary concentrating ability in Fischer 344 rats given continuous low doses of aspirin and paracetamol. Pathology 1990;22:33-44.
10. Mohandas J, Duggin GG, Horvath JS, Tiller DJ: Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P- 450 mixed- function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney. Toxicol Appl Pharmacol 1981;61: 252-259. (Pubitemid 12201474)
11. Mihatsch MJ, Khanlari B, Brunner FP: Obituary to analgesic nephropathy - an autopsy study. Nephrol DialTransplant 2006;21:3139-3145.
12. Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM: Analgesic use and renal function in men. JAMA 2001;286:315-321.
13. Chevalier RL, Forbes MS, Thornhill BA: Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 2009;75:1145-1152.
14. Kim H, Oda T, Lopez- Guisa J, Wing D, Edwards DR, Soloway PD, Eddy AA: TIMP- 1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2001;12:736-748.
15. Yang J, Shultz RW, Mars WM, Wegner RE, Li Y, Dai C, Nejak K, Liu Y: Disruption of tissue- type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 2002; 110:1525-1538.
16. Cheng S, Lovett DH. Gelatinase A (MMP- 2) is necessary and sufficient for renal tubular cell epithelialmesenchymal transformation. Am J Pathol 2003;162:1937-1949.
17. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR: Monocyte chemoattractant protein- 1 promotes macrophage- mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest:1999;103:73-80.
18. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ: Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 1999;56:571-580.
19. Lange- Sperandio B, Cachat F, Thornhill BA, Chevalier RL: Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. Kidney Int 2002;61:516-524.
20. Shimizu H, Maruyama S, Yuzawa Y, Kato T, Miki Y, Suzuki S, Sato W, Morita Y, Maruyama H, Egashira K, Matsuo S: Anti- monocyte chemoattractant protein- 1 gene therapy attenuates renal injury induced by protein- overload proteinuria. J Am Soc Nephrol 2003;14:1496-1505. (Pubitemid 36687051)
21. Persy VP, Verhulst A, Ysebaert DK, De Greef KE, De Broe ME: Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 2003;63:543-553.
22. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I: Absence of angiotensin II type 1 receptor in bone marrow- derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 2002;110:1859-1868.
23. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002;110:341-350.
24. Zeisberg M, Kalluri R: The role of epithelial- to- mesenchyml transition in renal fibrosis. J Mol Med 2004;82:175-181.
25. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ: Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound- microbubble system in rat UUO model. J Am Soc Nephrol 2003; 14:1535-1548.
26. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY: Smad7 inhibits fibrotic effect of TGF- Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002;13:1464-1472.
27. Li Y, Yang J, Dai C, Wu C, Liu Y: Role for integrin- linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003;112:503-516.
28. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP- 7 counteracts TGF- beta1- induced epithelial- tomesenchymal transition and reverses chronic renal injury. Nat Med 2003;9:964-968.
29. Kobayashi E, Sasamura H, Mifune M, Shimizu- Hirota R, Kuroda M, Hayashi M, Saruta T: Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts. Kidney Int 2003;64:1179-1188.
30. Yang J, Liu Y: Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002;13:96-107.
31. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH: Hypoxia promotes fibrogenesis in vivo via HIF- 1 stimulation of epithelial- tomesenchymal transition. J Clin Invest 2007;117:3810-3820.
32. Cano A, Perez- Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: The transcription factor snail controls epithelial- mesenchymal transitions by repressing E- cadherin expression. Nat Cell Biol 2000;2:76-83.
33. Carver EA, Jiang R, Lan Y, Oram KF, Gridley T: The mouse snail gene encodes a key regulator of the epithelial- mesenchymal transition. Mol Cell Biol 2001;21:8184-8188.
34. Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S, Liu L, Du R, Xia L, He L, Fan D: Hypoxia- inducible factor- 1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial- to- mesenchymal transition. Kidney Int 2009;75:1278-1287.
35. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ: Lysyl oxidase is essential for hypoxia- induced metastasis. Nature 2006;440:1222-1226.
36. Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB: Transforming growth factor- beta- dependent and - independent pathways of induction of tubulointerstitial fibrosis in beta6(- /- ) mice. Am J Pathol 2003;163:1261-1273.
37. Eddy AA, Fogo AB: Plasminogen activator inhibitor- 1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol 2006;17:2999-3012.
38. Woo D: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 1995;333:18-25.
39. Gobe GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 1987;56:273-281.
40. Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ: Accelerated apoptosis characterizes cyclosporineassociated interstitial fibrosis. Kidney Int 1998;53:897-908.
41. Schelling JR, Nkemere N, Kopp JB, Cleveland RP: Fas- dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 1998;78:813-824.
42. Khan S, Cleveland RP, Koch CJ, Schelling JR: Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 1999;79:1089-1099.
43. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, Venkatachalam MA: Role of hypoxiainduced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998;17:3401-3415.
44. Sanchez- Lozada LG, Soto V, Tapia E, Avila- Casado C, Sautin YY, Nakagawa T, Franco M, Rodriguez- Iturbe B, Johnson RJ: Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008;295: F1134-F1141.
45. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure- independent mechanism. Am J Physiol Renal Physiol 2002;282:F991-F997.
46. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-2897. (Pubitemid 35386908)
47. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
48. Eddy AA Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994;5:1273-1287.
49. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood- pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877-884. (Pubitemid 24094966)
50. Harris KP, Burton C, Walls J: Proteinuria: a mediator of interstitial fibrosis? Contrib Nephrol 1996;118:173-179.
51. Burton C, Harris KP: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765-775.
52. Tang S, Lai KN, Sacks SH: Role of complement in tubulointerstitial injury from proteinuria. Kidney Blood Press Res 2002;25:120-126.
53. Nangaku M, Pippin J, Couser WG: C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 2002;13:928-936.
54. Nangaku M, Pippin J, Couser WG: Complement membrane attack complex (C5b- 9) mediates interstitial disease in experimental nephritic syndrome. J Am Soc Nephrol 1999;10:2323-2331.
55. Matsuo S, Morita Y, Mizuno M, Nishikawa K, Yuzawa Y: Proteinuria and damage to tubular cells - is complement a culprit? Nephrol Dial Transplant 1998;13:2723-2726.
56. Kikuchi H, Kawachi H, Ito Y, Matsui K, Nosaka H, Saito A, Orikasa M, Arakawa M, Shimizu F: Severe proteinuria, sustained for 6 months, induces tubular epithelial cell injury and cell infiltration in rats but not progressive interstitial fibrosis. Nephrol Dial Transplant 2000;15:799-810.
57. Kato N, Watanabe Y, Ohno Y, Inoue T, Kanno Y, Suzuki H, Okada H: Mapping quantitative trait loci for proteinuria- induced renal collagen deposition. Kidney Int 2008; 73:1017-1023.
58. Healy E, Brady HR: Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr Opin Nephrol Hypertens 1998;7:525-530.
59. Schena FP, Gesualdo L, Grandaliano G, Montinaro V: Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? Kidney Int 1997;52:1439-1457.
60. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 1997;51:2-15. (Pubitemid 27064516)
61. Lan HY, Paterson DJ, Atkins RC: Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 1991;40:425-433.
62. Fine LG, Bandyopadhay D, Norman JT: Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 2000;75:S22-S26.
63. Tanaka T, Miyata T, Inagi R, Fujita T, Nangaku M: Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol 2004;165:1979-1992.
64. Schofield CJ, Ratcliffe PJ: Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004;5:343-354.
65. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia- inducible factor- 1alpha and - 2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002;13:1721-1732.
66. Tanaka T, Matsumoto M, Inagi R, Miyata T, Kojima I, Ohse T, Fujita T, Nangaku M: Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis. Kidney Int 2005;68: 2714-2725.
67. Tanaka T, Kojima I, Ohse T, Ingelfinger JR, Adler S, Fujita T, Nangaku M: Cobalt promotes angiogenesis via hypoxia- inducible factor and protects tubulointerstitium in the remnant kidney model. Lab Invest 2005;85:1292-1307.
68. Ohtomo S, Nangaku M, Izuhara Y, Takizawa S, Strihou CY, Miyata T: Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrol Dial Transplant 2008;23:1166-1172.
69. Kudo Y, Kakinuma Y, Mori Y, Morimoto N, Karashima T, Furihata M, Sato T, Shuin T, Sugiura T: Hypoxia- inducible factor- 1alpha is involved in the attenuation of experimentally induced rat glomerulonephritis. Nephron Exp Nephrol 2005;100:e95-e103.
70. Tanaka T, Nangaku M: Drug discovery for overcoming chronic kidney disease (CKD): prolyl- hydroxylase inhibitors to activate hypoxiainducible factor (HIF) as a novel therapeutic approach in CKD. J Pharmacol Sci 2009;109:24-31.
71. Nangaku M, Eckardt KU: Hypoxia and the HIF system in kidney disease. J Mol Med 2007;85:1325-1330.